Zaid Ahmed

Mr. Zaid Ahmed

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2026 in Urology
Verified
Journal Article
Open access
ZAZaid Ahmed
Zaid Ahmed
ECElia Abou Chawareb
Elia Abou Chawareb
MHMuhammed A.M. Hammad
Muhammed A.M. Hammad
SSSamet Senel
Samet Senel
YMYara Matar
Yara Matar
FYFaysal A. Yafi
Faysal A. Yafi

2 September 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
ZAZaid Ahmed
Zaid Ahmed
RSRashid Sayyid
Rashid Sayyid
OYOmid Yazdanpanah
Omid Yazdanpanah
RSRavand Samaeekia
Ravand Samaeekia
AKArash Rezazadeh Kalebasty
Arash Rezazadeh Kalebasty
Mohammed ShahaitMohammed Shahait
Mohammed Shahait
Therapeutic options for advanced prostate cancer have expanded in recent years, incorporating multiple-system treatment approaches with differing mechanisms of action. However, comparative real-world safety data following drug approval remain limited. As such, the aim of this study is to characterize adverse events and disproportionate safety signals among advanced prostate cancer therapies using the FDA Adverse Event Reporting System (FAERS). A retrospective pharmacovigilance study of FAERS reports evaluated enzalutamide, darolutamide, apalutamide, abiraterone acetate, relugolix, niraparib/abiraterone, talazoparib, rucaparib, cabazitaxel, sipuleucel-T, and lutetium-177 vipivotide. Adverse events were categorized by System Organ Class and Preferred Terms. Reporting odds ratios (RORs) with 95% confidence intervals identified safety signals. Among 172,440 reports, most involved patients aged 65–85 years. Cabazitaxel had the highest proportion of serious reports (86.6%) and deaths (22%), whereas relugolix had the lowest (23.3% and 4.8%). Nervous system disorders predominated with enzalutamide and darolutamide, gastrointestinal disorders with abiraterone, rucaparib, and niraparib/abiraterone, and hematologic toxicities with cabazitaxel, talazoparib, and lutetium-177 vipivotide. Significant safety signals were identified for abiraterone and cabazitaxel, but not other therapies. The absence of a detected signal should not be interpreted as evidence of safety or equivalence, as reporting volume, detection bias, and statistical power varied across therapies. Overall, the therapies demonstrated distinct toxicity profiles, which may inform treatment selection, toxicity monitoring, and patient counseling.

17 December 2025 in Trends in Urology & Men's Health
Verified
Journal Article
Open access
ZAZaid Ahmed
Zaid Ahmed
MHMuhammed A Moukhtar Hammad
Muhammed A Moukhtar Hammad
ECElia Abou Chawareb
Elia Abou Chawareb
GGGustavo Gryzinski
Gustavo Gryzinski
FYFaysal A. Yafi
Faysal A. Yafi
JYJessica Yih
Jessica Yih
Dobbs v. Jackson Women's Health Organization was one of the most pivotal cases regarding reproductive health and women's rights in recent history. The case resulted in the removal of the constitutional right to abortion for women across the United States. This study analyzes how the case influenced Google search trends for widely searched reproductive health terms. Google search volumes for five popular reproductive surgeries were collected between June 2020 and June 2024, 2 years before and after the overruling of Roe v. Wade on June 24, 2022. The search terms included were “salpingectomy,” “vasectomy,” “tubal ligation,” “vasectomy reversal,” and “hysterectomy.” Google search trends provided data for each of the terms on a scale from 0 to 100. The terms were then compared in terms of popularity to determine which procedure was most popular in relation to the case. Significant spikes in interest were found for all the search terms in response to the decision. In general, searches for hysterectomy ( R 2 = 0.3658) had the greatest interest, followed by vasectomy ( R 2 = 0.1722). The remaining terms had minimal interest in comparison, with tubal ligation ( R 2 = 0.0314), vasectomy reversal ( R 2 = 0.037), and salpingectomy ( R 2 = 0.7034) following in order of greatest to least interest. The findings highlight the significant impact the Dobbs v. Jackson Women's Health Organization decision had on public interest in reproductive procedures. These insights show how judicial rulings, legislative changes, and media coverage shape public interest in reproductive health across the United States.

7 January 2026 in The Journal of Sexual Medicine
Verified
Journal Article
Open access
ZAZaid Ahmed
Zaid Ahmed
OMOlivia F Madalone
Olivia F Madalone
ECElia Abou Chawareb
Elia Abou Chawareb
MHMuhammed A Moukhtar Hammad
Muhammed A Moukhtar Hammad
JMJake Miller
Jake Miller
FYFaysal A Yafi
Faysal A Yafi

2 July 2026 in Sexual Medicine
Verified
Journal Article
Open access
SQSophia Quesada
Sophia Quesada
ZAZaid Ahmed
Zaid Ahmed
HNHana S Nakamura
Hana S Nakamura
YKYash H Kadakia
Yash H Kadakia
ECElia Abou Chawareb
Elia Abou Chawareb
FYFaysal A Yafi
Faysal A Yafi
Background: Despite increasing use of peptides in sexual medicine, interstate differences in access are not fully explained by federal approval status and may instead reflect variation in state-level healthcare delivery structures. Aim: To systematically compare state-level environments affecting access to peptide-based sexual medicine therapies using objective proxy measures and to generate a clinician-friendly framework for identifying geographic disparities. Methods: We conducted a cross-sectional, state-level analysis of all 50 U.S. states and the District of Columbia. Access environments were characterized using three reproducible proxy variables reflecting clinical feasibility of care: (1) telehealth prescribing permissiveness, (2) nurse practitioner (NP) practice authority, and (3) availability of FDA-registered 503B outsourcing facilities normalized by population. Each variable was coded on a standardized scale and averaged to generate a compositive Peptide Access Environment Score (PAES). States were stratified into high-, moderate-, and low-access tiers. Regional differences were evaluated using nonparametric statistical testing and geographic visualization. Outcomes: Primary outcomes included state-level PAES values and access tier classification. Secondary outcomes included regional variation and concordance between telehealth regulation and compounding infrastructure. Results: PAES values ranged from 0.33 to 1.56, demonstrating substantial interstate variability. High-access environments clustered predominantly in the Northeast and West, while low-access states were most frequently observed in the South and parts of the Midwest. Regional differences in PAES were statistically significant (p < .001). Discordance between telehealth prescribing permissiveness and compounding infrastructure was identified, with multiple states permitting telehealth initiation of care despite lacking in-state 503B facilities, and others possessing compounding capacity but maintaining restrictive telehealth regulations. Clinical implications: State-level healthcare delivery policies and infrastructure may meaningfully influence patient access to peptide-based sexual medicine therapies independent of peptide-specific regulatory status. Strengths and limitations: Strengths include a transparent, reproducible methodology using publicly available data and a clinically grounded, multidimensional access framework. Limitations include reliance on proxy measures, exclusion of physician assistant autonomy, and inability to assess within-state socioeconomic or urban–rural heterogeneity. Conclusion: Interstate differences in telemedicine permissiveness, NP practice authority, and compounding infrastructure are associated with significant geographic disparities in access to peptide-based sexual medicine therapies in the United States.

Verified
Journal Article
Open access
PDF file
ZAZaid Ahmed
Zaid Ahmed
MHMuhammed A Moukhtar Hammad
Muhammed A Moukhtar Hammad
JMJake Miller
Jake Miller
ECElia Abou Chawareb
Elia Abou Chawareb
LJLawrence C. Jenkins
Lawrence C. Jenkins
FYFaysal A. Yafi
Faysal A. Yafi
Background/Objectives: Erectile dysfunction (ED) significantly impacts the well-being and quality of life of millions of men. Understanding geographic patterns and associated factors influencing ED search trends can offer valuable insights for healthcare improvement and advocacy. This study investigated the correlation between Google search trends for ED and various factors across the US. Methods: Google search trends for “erectile dysfunction” were collected over a 6-year period between March 2018 and August 2024. The Google search trends provided data for individual states on a scale from 1 to 100. Search volumes were analyzed alongside the urologist-to-population ratio, percentage of the population aged 65 and older, median household income, and percentage of state residents with a bachelor’s degree or higher. Pearson correlation coefficients were used to examine the relationships between ED search volumes and these factors. Results: Higher ED search volumes were associated with a higher percentage of older adults (r = 0.4332, p = 0.001676). A negative correlation was found between ED search volume and higher education (r = −0.482, p = 0.000394). No significant correlation was found between median household income and ED search volume (r = −0.201, p = 0.164) or a greater urologist density (r = 0.0612, p = 0.6729). Conclusions: This study highlights how healthcare access and demographics influence ED search trends. States with older, less educated populations showed higher interest, while wealthier areas with more urologists had no significant correlation. These findings can guide targeted interventions to improve sexual care in underserved regions.